Medicaid Rebate Cases To Focus On “Slam Dunks”; Industry Wants Guidance
Guidance for pharmaceutical manufacturers regarding compliance with the Medicaid rebate statute will most likely be obtained through regulations rather than case law, a former Department of Justice lawyer said
You may also be interested in...
The Securities & Exchange Commission is asking King to provide information about its Medicaid rebate calculations as part of a broad subpoena disclosed by the company March 11
Schering-Plough is estimating its "minimum liability" in pending investigations of its marketing practices at the low end of recent settlements within the pharmaceutical industry
The Bush Administration is proposing to eliminate the "best price" component of the Medicaid rebate system - and require a deeper mandatory discount